New York-based pharmaceutical giant Bristol-Myers Squibb on Thursday announced it would buy US biotech firm Celgene in a $74 billion cash-and-stock deal, creating a rival to the world's largest drug makers.
Business
Jan 3, 2019
0
10
As 2018 draws to a close, the pharmaceutical industry is celebrating a prosperous year of new investments and therapeutic breakthroughs. These successes were driven by cutting-edge science and progress in finally translating ...
Other
Dec 5, 2018
0
6
CRISPR could potentially engineer super crops, make designer animal models for research and even snip out genetic diseases. Experts say that billions of dollars are at stake.
Other
Jan 9, 2017
0
6
Cuba has unveiled its first manufactured nanopharmaceutical drug—a tweaked variety of cyclosporine, used to help prevent transplant rejection—official media reported Saturday.
Bio & Medicine
Sep 23, 2012
1
0
(AP) -- The Vatican has entered into an unusual partnership with a small U.S. biotech company to promote using adult stem cells for treating disease, rather than focusing research on embryonic stem cells.
Other
Nov 9, 2011
0
0
The biotech industry boosted farming across the globe to the tune of almost $65 billion during the period 1996 to 2009, according to the latest analysis published in the International Journal of Biotechnology. $65 billion ...
Biotechnology
Sep 19, 2011
3
0
It isn't often that you see heavyweights in the tech world duking it out in a high-stakes match, with Congress as the referee. It's happening today over proposed reforms in patent law, which pits the software and information ...
Business
Apr 7, 2009
0
0
